Your browser doesn't support javascript.
loading
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity-score matched analysis.
Patel, Romil; Ma, Junsheng; Bashir, Qaiser; Delgado, Ruby; Rondon, Gabriela; Popat, Uday R; Hosing, Chitra M; Nieto, Yago; Kebriaei, Partow; Alousi, Amin M; Daher, May; Mehta, Rohtesh; Srour, Samer; Weber, Donna M; Thomas, Sheeba K; Lee, Hans C; Patel, Krina K; Orlowski, Robert Z; Shpall, Elizabeth S; Champlin, Richard E; Saini, Neeraj; Qazilbash, Muzaffar H.
Afiliação
  • Patel R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Ma J; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Delgado R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Rondon G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Popat UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Hosing CM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Alousi AM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Daher M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Mehta R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Srour S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Weber DM; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Thomas SK; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Lee HC; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Patel KK; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Shpall ES; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 96(12): E455-E457, 2021 12 01.
Article em En | MEDLINE | ID: mdl-34559916

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article